Risk factors for central line-associated bloodstream infections in the era of prevention bundles

Infection Control and Hospital Epidemiology

Volumn 36, Issue 2, 2015, Pages 214-216

  Callister, Devin ^a   Limchaiyawat, Pauline ^a   Eells, Samantha ^a,b   Miller, Loren G ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE;

ARTICLE; CARE BUNDLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; HEMODYNAMIC MONITORING; HUMAN; MALE; MATHEMATICAL MODEL; RETROSPECTIVE STUDY; RISK FACTOR; ADULT; ADVERSE EFFECTS; AGED; BLOOD ANALYSIS; BLOOD EXAMINATION; CASE CONTROL STUDY; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; DEVICES; MIDDLE AGED; PHYSIOLOGIC MONITORING; TIME; UTILIZATION;

ADULT; AGED; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; FEMALE; HEMATOLOGIC TESTS; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT CARE BUNDLES; RISK FACTORS; TIME FACTORS;

EID: 84922729858     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2014.32     Document Type: Article

References (10)

1. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-2732.
2. Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011; 60:243-248.
3. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S22-S30.
4. Berenholtz SM, Lubomski LH, Weeks K, et al. Eliminating central line-associated bloodstream infections: a national patient safety imperative. Infect Control Hosp Epidemiol 2014;35:56-62.
5. Lukenbill J, Rybicki L, Sekeres MA, et al. Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2013;19:720-724.
6. Pongruangporn M, Ajenjo MC, Russo AJ, et al. Patient-and device-specific risk factors for peripherally inserted central venous catheter-related bloodstream infections. Infect Control Hosp Epidemiol 2013;34:184-189.
7. Saman DM, Kavanagh KT, Johnson B, et al. Can inpatient hospital experiences predict central line-associated bloodstream infections? PLOS ONE 2013;8:e61097. doi:10.1371/journal. pone.0061097
8. Centers for Disease Control and Prevention (CDC), National Healthcare Safety Network (NHSN) Surveillance Definitions: Central Line Associated Bloodstream Infection (CLABSI) & Related Sites. July 2013. http://www.cdc.gov/nhsn/pdfs/pscmanual/ 17pscnosinfdef_current.pdf
9. Lissauer ME, Leeka S, Preas MA, et al. Risk factors for central line-associated bloodstream infections in the era of best practice. J Trauma Acute Care Surg 2012;72:1174-1180.
10. Lockman JL1, Heitmiller ES, Ascenzi JA, Berkowitz I. Scrub the hub! Catheter needleless port decontamination. Anesthesiology 2011;114:958.